Cargando…

Development of Nanomaterials to Target Articular Cartilage for Osteoarthritis Therapy

Osteoarthritis (OA) is an obstinate, degradative, and complicated disease that has drawn much attention worldwide. Characterized by its stubborn symptoms and various sequela, OA causes much financial burden on both patients and the health system. What’s more, conventional systematic therapy is not e...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Chenyu, Shi, Sirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402910/
https://www.ncbi.nlm.nih.gov/pubmed/36032667
http://dx.doi.org/10.3389/fmolb.2022.900344
_version_ 1784773249335296000
author Rao, Chenyu
Shi, Sirong
author_facet Rao, Chenyu
Shi, Sirong
author_sort Rao, Chenyu
collection PubMed
description Osteoarthritis (OA) is an obstinate, degradative, and complicated disease that has drawn much attention worldwide. Characterized by its stubborn symptoms and various sequela, OA causes much financial burden on both patients and the health system. What’s more, conventional systematic therapy is not effective enough and causes multiple side effects. There’s much evidence that nanoparticles have unique properties such as high penetration, biostability, and large specific surface area. Thus, it is urgent to exploit novel medications for OA. Nanomaterials have been sufficiently studied, exploiting diverse nano-drug delivery systems (DDSs) and targeted nano therapeutical molecules. The nanomaterials are primarily intra-articular injected under the advantages of high topical concentration and low dosage. After administration, the DDS and targeted nano therapeutical molecules can specifically react with the components, including cartilage and synovium of a joint in OA, furthermore attenuate the chondrocyte apoptosis, matrix degradation, and macrophage recruitment. Thus, arthritis would be alleviated. The DDSs could load with conventional anti-inflammatory drugs, antibodies, RNA, and so on, targeting chondrocytes, synovium, or extracellular matrix (ECM) and releasing the molecules sequentially. The targeted nano therapeutical molecules could directly get to the targeted tissue, alleviating the inflammation and promoting tissue healing. This review will comprehensively collect and evaluate the targeted nanomaterials to articular cartilage in OA.
format Online
Article
Text
id pubmed-9402910
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94029102022-08-26 Development of Nanomaterials to Target Articular Cartilage for Osteoarthritis Therapy Rao, Chenyu Shi, Sirong Front Mol Biosci Molecular Biosciences Osteoarthritis (OA) is an obstinate, degradative, and complicated disease that has drawn much attention worldwide. Characterized by its stubborn symptoms and various sequela, OA causes much financial burden on both patients and the health system. What’s more, conventional systematic therapy is not effective enough and causes multiple side effects. There’s much evidence that nanoparticles have unique properties such as high penetration, biostability, and large specific surface area. Thus, it is urgent to exploit novel medications for OA. Nanomaterials have been sufficiently studied, exploiting diverse nano-drug delivery systems (DDSs) and targeted nano therapeutical molecules. The nanomaterials are primarily intra-articular injected under the advantages of high topical concentration and low dosage. After administration, the DDS and targeted nano therapeutical molecules can specifically react with the components, including cartilage and synovium of a joint in OA, furthermore attenuate the chondrocyte apoptosis, matrix degradation, and macrophage recruitment. Thus, arthritis would be alleviated. The DDSs could load with conventional anti-inflammatory drugs, antibodies, RNA, and so on, targeting chondrocytes, synovium, or extracellular matrix (ECM) and releasing the molecules sequentially. The targeted nano therapeutical molecules could directly get to the targeted tissue, alleviating the inflammation and promoting tissue healing. This review will comprehensively collect and evaluate the targeted nanomaterials to articular cartilage in OA. Frontiers Media S.A. 2022-08-11 /pmc/articles/PMC9402910/ /pubmed/36032667 http://dx.doi.org/10.3389/fmolb.2022.900344 Text en Copyright © 2022 Rao and Shi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Rao, Chenyu
Shi, Sirong
Development of Nanomaterials to Target Articular Cartilage for Osteoarthritis Therapy
title Development of Nanomaterials to Target Articular Cartilage for Osteoarthritis Therapy
title_full Development of Nanomaterials to Target Articular Cartilage for Osteoarthritis Therapy
title_fullStr Development of Nanomaterials to Target Articular Cartilage for Osteoarthritis Therapy
title_full_unstemmed Development of Nanomaterials to Target Articular Cartilage for Osteoarthritis Therapy
title_short Development of Nanomaterials to Target Articular Cartilage for Osteoarthritis Therapy
title_sort development of nanomaterials to target articular cartilage for osteoarthritis therapy
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402910/
https://www.ncbi.nlm.nih.gov/pubmed/36032667
http://dx.doi.org/10.3389/fmolb.2022.900344
work_keys_str_mv AT raochenyu developmentofnanomaterialstotargetarticularcartilageforosteoarthritistherapy
AT shisirong developmentofnanomaterialstotargetarticularcartilageforosteoarthritistherapy